Drug Eluting Stent Market

Global Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Regional Outlook and Forecast, 2023 - 2030

Report Id: KBV-17426 Publication Date: September-2023 Number of Pages: 350
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Drug Eluting Stent Market, by Application
1.4.2 Global Drug Eluting Stent Market, by Coating Type
1.4.3 Global Drug Eluting Stent Market, by Geography
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis

Chapter 4. Global Drug Eluting Stent Market by Application
4.1 Global Coronary Artery Disease Market by Region
4.2 Global Peripheral Artery Disease Market by Region

Chapter 5. Global Drug Eluting Stent Market by Coating Type
5.1 Global Polymer-based Coating Market by Region
5.2 Global Drug Eluting Stent Market by Polymer-based Coating Type
5.2.1 Global Non-biodegradable Polymers Market by Region
5.2.2 Global Biodegradable Polymers Market by Region
5.3 Global Polymer-free Coating Market by Region
5.4 Global Drug Eluting Stent Market by Polymer-free Coating Type
5.4.1 Global Micro Porous Surface Market by Region
5.4.2 Global Micro Structured Surface Market by Region
5.4.3 Global Slotted Tubular Surface Market by Region
5.4.4 Global Nanoporous Surface Market by Region

Chapter 6. Global Drug Eluting Stent Market by Region
6.1 North America Drug Eluting Stent Market
6.1.1 North America Drug Eluting Stent Market by Application
6.1.1.1 North America Coronary Artery Disease Market by Country
6.1.1.2 North America Peripheral Artery Disease Market by Country
6.1.2 North America Drug Eluting Stent Market by Coating Type
6.1.2.1 North America Polymer-based Coating Market by Country
6.1.2.2 North America Drug Eluting Stent Market by Polymer-based Coating Type
6.1.2.2.1 North America Non-biodegradable Polymers Market by Country
6.1.2.2.2 North America Biodegradable Polymers Market by Country
6.1.2.3 North America Polymer-free Coating Market by Country
6.1.2.4 North America Drug Eluting Stent Market by Polymer-free Coating Type
6.1.2.4.1 North America Micro Porous Surface Market by Country
6.1.2.4.2 North America Micro Structured Surface Market by Country
6.1.2.4.3 North America Slotted Tubular Surface Market by Country
6.1.2.4.4 North America Nanoporous Surface Market by Country
6.1.3 North America Drug Eluting Stent Market by Country
6.1.3.1 US Drug Eluting Stent Market
6.1.3.1.1 US Drug Eluting Stent Market by Application
6.1.3.1.2 US Drug Eluting Stent Market by Coating Type
6.1.3.2 Canada Drug Eluting Stent Market
6.1.3.2.1 Canada Drug Eluting Stent Market by Application
6.1.3.2.2 Canada Drug Eluting Stent Market by Coating Type
6.1.3.3 Mexico Drug Eluting Stent Market
6.1.3.3.1 Mexico Drug Eluting Stent Market by Application
6.1.3.3.2 Mexico Drug Eluting Stent Market by Coating Type
6.1.3.4 Rest of North America Drug Eluting Stent Market
6.1.3.4.1 Rest of North America Drug Eluting Stent Market by Application
6.1.3.4.2 Rest of North America Drug Eluting Stent Market by Coating Type
6.2 Europe Drug Eluting Stent Market
6.2.1 Europe Drug Eluting Stent Market by Application
6.2.1.1 Europe Coronary Artery Disease Market by Country
6.2.1.2 Europe Peripheral Artery Disease Market by Country
6.2.2 Europe Drug Eluting Stent Market by Coating Type
6.2.2.1 Europe Polymer-based Coating Market by Country
6.2.2.2 Europe Drug Eluting Stent Market by Polymer-based Coating Type
6.2.2.2.1 Europe Non-biodegradable Polymers Market by Country
6.2.2.2.2 Europe Biodegradable Polymers Market by Country
6.2.2.3 Europe Polymer-free Coating Market by Country
6.2.2.4 Europe Drug Eluting Stent Market by Polymer-free Coating Type
6.2.2.4.1 Europe Micro Porous Surface Market by Country
6.2.2.4.2 Europe Micro Structured Surface Market by Country
6.2.2.4.3 Europe Slotted Tubular Surface Market by Country
6.2.2.4.4 Europe Nanoporous Surface Market by Country
6.2.3 Europe Drug Eluting Stent Market by Country
6.2.3.1 Germany Drug Eluting Stent Market
6.2.3.1.1 Germany Drug Eluting Stent Market by Application
6.2.3.1.2 Germany Drug Eluting Stent Market by Coating Type
6.2.3.2 UK Drug Eluting Stent Market
6.2.3.2.1 UK Drug Eluting Stent Market by Application
6.2.3.2.2 UK Drug Eluting Stent Market by Coating Type
6.2.3.3 France Drug Eluting Stent Market
6.2.3.3.1 France Drug Eluting Stent Market by Application
6.2.3.3.2 France Drug Eluting Stent Market by Coating Type
6.2.3.4 Russia Drug Eluting Stent Market
6.2.3.4.1 Russia Drug Eluting Stent Market by Application
6.2.3.4.2 Russia Drug Eluting Stent Market by Coating Type
6.2.3.5 Spain Drug Eluting Stent Market
6.2.3.5.1 Spain Drug Eluting Stent Market by Application
6.2.3.5.2 Spain Drug Eluting Stent Market by Coating Type
6.2.3.6 Italy Drug Eluting Stent Market
6.2.3.6.1 Italy Drug Eluting Stent Market by Application
6.2.3.6.2 Italy Drug Eluting Stent Market by Coating Type
6.2.3.7 Rest of Europe Drug Eluting Stent Market
6.2.3.7.1 Rest of Europe Drug Eluting Stent Market by Application
6.2.3.7.2 Rest of Europe Drug Eluting Stent Market by Coating Type
6.3 Asia Pacific Drug Eluting Stent Market
6.3.1 Asia Pacific Drug Eluting Stent Market by Application
6.3.1.1 Asia Pacific Coronary Artery Disease Market by Country
6.3.1.2 Asia Pacific Peripheral Artery Disease Market by Country
6.3.2 Asia Pacific Drug Eluting Stent Market by Coating Type
6.3.2.1 Asia Pacific Polymer-based Coating Market by Country
6.3.2.2 Asia Pacific Drug Eluting Stent Market by Polymer-based Coating Type
6.3.2.2.1 Asia Pacific Non-biodegradable Polymers Market by Country
6.3.2.2.2 Asia Pacific Biodegradable Polymers Market by Country
6.3.2.3 Asia Pacific Polymer-free Coating Market by Country
6.3.2.4 Asia Pacific Drug Eluting Stent Market by Polymer-free Coating Type
6.3.2.4.1 Asia Pacific Micro Porous Surface Market by Country
6.3.2.4.2 Asia Pacific Micro Structured Surface Market by Country
6.3.2.4.3 Asia Pacific Slotted Tubular Surface Market by Country
6.3.2.4.4 Asia Pacific Nanoporous Surface Market by Country
6.3.3 Asia Pacific Drug Eluting Stent Market by Country
6.3.3.1 China Drug Eluting Stent Market
6.3.3.1.1 China Drug Eluting Stent Market by Application
6.3.3.1.2 China Drug Eluting Stent Market by Coating Type
6.3.3.2 Japan Drug Eluting Stent Market
6.3.3.2.1 Japan Drug Eluting Stent Market by Application
6.3.3.2.2 Japan Drug Eluting Stent Market by Coating Type
6.3.3.3 India Drug Eluting Stent Market
6.3.3.3.1 India Drug Eluting Stent Market by Application
6.3.3.3.2 India Drug Eluting Stent Market by Coating Type
6.3.3.4 South Korea Drug Eluting Stent Market
6.3.3.4.1 South Korea Drug Eluting Stent Market by Application
6.3.3.4.2 South Korea Drug Eluting Stent Market by Coating Type
6.3.3.5 Singapore Drug Eluting Stent Market
6.3.3.5.1 Singapore Drug Eluting Stent Market by Application
6.3.3.5.2 Singapore Drug Eluting Stent Market by Coating Type
6.3.3.6 Malaysia Drug Eluting Stent Market
6.3.3.6.1 Malaysia Drug Eluting Stent Market by Application
6.3.3.6.2 Malaysia Drug Eluting Stent Market by Coating Type
6.3.3.7 Rest of Asia Pacific Drug Eluting Stent Market
6.3.3.7.1 Rest of Asia Pacific Drug Eluting Stent Market by Application
6.3.3.7.2 Rest of Asia Pacific Drug Eluting Stent Market by Coating Type
6.4 LAMEA Drug Eluting Stent Market
6.4.1 LAMEA Drug Eluting Stent Market by Application
6.4.1.1 LAMEA Coronary Artery Disease Market by Country
6.4.1.2 LAMEA Peripheral Artery Disease Market by Country
6.4.2 LAMEA Drug Eluting Stent Market by Coating Type
6.4.2.1 LAMEA Polymer-based Coating Market by Country
6.4.2.2 LAMEA Drug Eluting Stent Market by Polymer-based Coating Type
6.4.2.2.1 LAMEA Non-biodegradable Polymers Market by Country
6.4.2.2.2 LAMEA Biodegradable Polymers Market by Country
6.4.2.3 LAMEA Polymer-free Coating Market by Country
6.4.2.4 LAMEA Drug Eluting Stent Market by Polymer-free Coating Type
6.4.2.4.1 LAMEA Micro Porous Surface Market by Country
6.4.2.4.2 LAMEA Micro Structured Surface Market by Country
6.4.2.4.3 LAMEA Slotted Tubular Surface Market by Country
6.4.2.4.4 LAMEA Nanoporous Surface Market by Country
6.4.3 LAMEA Drug Eluting Stent Market by Country
6.4.3.1 Brazil Drug Eluting Stent Market
6.4.3.1.1 Brazil Drug Eluting Stent Market by Application
6.4.3.1.2 Brazil Drug Eluting Stent Market by Coating Type
6.4.3.2 Argentina Drug Eluting Stent Market
6.4.3.2.1 Argentina Drug Eluting Stent Market by Application
6.4.3.2.2 Argentina Drug Eluting Stent Market by Coating Type
6.4.3.3 UAE Drug Eluting Stent Market
6.4.3.3.1 UAE Drug Eluting Stent Market by Application
6.4.3.3.2 UAE Drug Eluting Stent Market by Coating Type
6.4.3.4 Saudi Arabia Drug Eluting Stent Market
6.4.3.4.1 Saudi Arabia Drug Eluting Stent Market by Application
6.4.3.4.2 Saudi Arabia Drug Eluting Stent Market by Coating Type
6.4.3.5 South Africa Drug Eluting Stent Market
6.4.3.5.1 South Africa Drug Eluting Stent Market by Application
6.4.3.5.2 South Africa Drug Eluting Stent Market by Coating Type
6.4.3.6 Nigeria Drug Eluting Stent Market
6.4.3.6.1 Nigeria Drug Eluting Stent Market by Application
6.4.3.6.2 Nigeria Drug Eluting Stent Market by Coating Type
6.4.3.7 Rest of LAMEA Drug Eluting Stent Market
6.4.3.7.1 Rest of LAMEA Drug Eluting Stent Market by Application
6.4.3.7.2 Rest of LAMEA Drug Eluting Stent Market by Coating Type

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Mergers & Acquisition:
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Terumo Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations & Agreements:
7.3.6 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Trials and Approvals:
7.4.5.2 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.3 SWOT Analysis
7.6 Cook Medical, Inc. (Cook Group)
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Biotronik SE & Co. KG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Lepu Medical Technology Co., Ltd
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Alvimedica
7.10.1 Company Overview
7.10.2 SWOT Analysis

Chapter 8. Winning Imperative for Drug Eluting Stent Market
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo